ACS medicinal chemistry letters · 2025
Development and Evaluation of 1‑Hydroxypyridin-2(1H)‑one Derivatives as Antibacterial Agents against Pathogenic Pseudomonas aeruginosa.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nayak Sandesha, Girmay Berehe Solomon, Byun Ha Jeong, Kim Seong Soon, Yu Sunjong, Hwang Jun Yeon, Kim Hyung Jun, Lee Hyunjung, Lee Joo-Youn, Lee Haemi, Bae Myung Ae, Yun Chang-Soo, Jang Soojin, Suh Jeehee, Song Saemee, Han Soo Bong, Kim Hyejin
Аннотация
The global rise of multidrug-resistant bacteria has prompted an urgent need for new antibiotics, yet resistance continues to outpace discovery due to Gram-negative barriers, drug permeability issues, and limited industry investment. In this study, we synthesized a series of 1-hydroxypyridin-2-(1H)-one derivatives targeting Pseudomonas aeruginosa for analyses of antibacterial efficacy. Among these, LP07 displayed potent antibacterial activity across multiple strains, enhanced by subinhibitory colistin. Scanning electron microscopy suggested membrane-associated morphological changes, including surface collapse, shrinkage, and irregular cell shape, consistent with bactericidal effects. Safety profiling showed low CYP inhibition, minimal hERG liability, and no mammalian cytotoxicity. Taken together, LP07's whole-cell activity and observed membrane effects support its promise as a lead for further optimization.